Tsai JC, Wang H, Perrella MA, Yoshizumi M, Sibinga NES, Tan LC, Haber E, Chang THT, Schlegel R, and Lee ME (1996)
The company is on track to provide an update on the INLIGHT clinical trial for WVE-007, an investigational treatment for obesity, in Q1 2026, with plans to initiate a Phase 2a trial in individuals with gher BMI
Translational population target binding model for the anti-FcRn fragment antibody efgartigimod
Data from a review of patient experiences and surveys involving more than 2200 patients with B12 deficiency in the UK indicate that many patients have concerns related to healthcare quality, safety, and treatment, with nearly two-thirds of respondents reporting that their treatment is insufficient to manage symptoms
JAMA 2017;318:11824
Researching suppliers and verifying product authenticity can prevent the risks associated with counterfeit or contaminated peptides